V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10478991 | 10054566 | 1.68 | 99.4 | Palliative (P) | 2019-08-07 | 2019-08-14 | Avelumab | 02 | N | NIVOLUMAB | 100486701 |
| 10479016 | 10054567 | 1.66 | 63.4 | Palliative (P) | 2019-01-16 | 2019-01-22 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101833345 |
| 10479076 | 10054568 | 1.71 | 68.3 | Palliative (P) | 2018-10-29 | 2018-11-10 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100290694 |
| 10479133 | 10054569 | 1.75 | 60.3 | 03 | 2018-01-07 | 2018-01-10 | Avelumab | 02 | N | RUXOLITINIB | 101522080 |
| 10479181 | 10054570 | null | 70 | Palliative (P) | null | 2016-12-03 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101209799 |
| 10479207 | 10054571 | null | 95.5 | Adjuvant (A) | 2019-09-13 | 2019-10-07 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100766356 |
| 10479227 | 10054572 | 1.56 | 75.2 | null | 2019-11-20 | 2019-11-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100921521 |
| 10479247 | 10054573 | 1.7 | null | null | 2021-12-26 | 2022-01-10 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101116360 |
| 10479274 | 10054574 | 1.67 | 73 | Adjuvant (A) | 2019-02-10 | 2019-02-10 | DARATUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN | 101274669 |
| 10479315 | 10054575 | 1.76 | 71.5 | 03 | null | 2020-05-25 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100216681 |
| 10479353 | 10054576 | 1.77 | 58.7 | Palliative (P) | 2017-06-12 | 2017-07-16 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100605319 |
| 10479354 | 10054577 | 1.73 | 86.6 | Palliative (P) | 2019-06-19 | 2019-06-24 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100308512 |
| 10479358 | 10054578 | 1.75 | 75.4 | Palliative (P) | 2017-10-16 | 2017-11-04 | Venetoclax | 02 | N | VENETOCLAX | 100276862 |
| 10479374 | 10054579 | 0 | 78.5 | null | 2022-03-20 | 2022-03-30 | Venetoclax | 02 | null | AVELUMAB | 100813712 |
| 10479391 | 10054580 | 1.8 | 76.2 | null | 2018-05-05 | 2018-05-07 | Avelumab | 02 | null | DARATUMUMAB | 101681733 |
| 10479398 | 10054581 | 1.73 | 64.4 | null | 2021-11-08 | 2021-11-29 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101313539 |
| 10479402 | 10054582 | 1.73 | 59.8 | null | 2022-03-03 | 2022-03-20 | Avelumab | 02 | null | VENETOCLAX | 100035866 |
| 10479412 | 10054583 | 1.8 | 94.6 | null | 2021-11-16 | 2021-11-18 | Oxaliplatin + Modified de Gramont | null | null | FLUOROURACIL + OXALIPLATIN | 101698747 |
| 10479432 | 10054584 | 1.69 | 95 | null | 2020-03-04 | 2020-03-04 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100474349 |
| 10479436 | 10054585 | 0 | 71.4 | null | 2021-06-09 | 2021-06-19 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100077663 |
| 10479502 | 10054586 | 1.5 | 87.6 | Curative (C) | 2021-04-26 | 2021-05-07 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100445527 |
| 10479543 | 10054587 | 1.71 | 93.3 | null | 2018-10-25 | 2018-11-30 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100512914 |
| 10479574 | 10054588 | 1.68 | 86 | Palliative (P) | 2018-04-08 | 2018-04-21 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100198509 |
| 10479582 | 10054589 | 1.63 | 73.5 | Palliative (P) | 2019-02-27 | 2019-04-26 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101453984 |
| 10479585 | 10054590 | 1.62 | 64.5 | Palliative (P) | 2022-04-13 | 2022-05-04 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100950267 |
| 10479648 | 10054591 | 1.64 | 80.2 | null | 2017-03-03 | 2017-03-04 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101057896 |
| 10479706 | 10054592 | 1.72 | 76.7 | Palliative (P) | 2017-11-06 | 2017-11-22 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100036254 |
| 10479709 | 10054593 | 1.71 | 80 | Palliative (P) | 2017-02-24 | 2017-02-24 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100469882 |
| 10479756 | 10054594 | 1.73 | 77.8 | null | 2020-02-21 | 2020-02-21 | Avelumab | 02 | null | AVELUMAB | 100059656 |
| 10479792 | 10054595 | 1.58 | 73.4 | null | 2021-01-20 | 2021-01-21 | NIVOLUMAB | 02 | null | DARATUMUMAB | 100215686 |
| 10479793 | 10054596 | 0 | 88.4 | null | 2017-12-31 | 2018-01-21 | Avelumab | 02 | null | TRASTUZUMAB | 100606778 |
| 10479827 | 10054597 | 0 | null | null | 2021-05-11 | 2021-05-13 | Avelumab | null | N | RUXOLITINIB | 101459334 |
| 10479851 | 10054598 | 1.63 | 79.8 | null | 2021-08-17 | 2021-09-05 | Avelumab | 02 | null | DARATUMUMAB | 101838333 |
| 10479852 | 10054599 | 1.62 | 76 | Palliative (P) | 2015-09-12 | 2015-09-28 | Venetoclax | 02 | N | VENETOCLAX | 100994420 |
| 10479860 | 10054600 | 1.66 | 151.2 | null | 2017-11-11 | 2017-11-21 | Avelumab | 02 | null | DARATUMUMAB | 101339784 |
| 10479878 | 10054601 | 1.8 | 83.8 | Curative (C) | 2018-07-06 | 2018-07-06 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101118218 |
| 10479885 | 10054602 | 1.82 | 59 | 03 | 2019-07-07 | 2019-07-11 | Avelumab | 02 | N | VENETOCLAX | 100253426 |
| 10479921 | 10054603 | 1.7 | 86 | null | 2016-06-21 | 2016-07-03 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101145062 |
| 10479978 | 10054604 | 1.65 | 79.8 | Palliative (P) | null | 2016-03-29 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101687911 |
| 10479988 | 10054605 | null | 64 | Disease modification (D) | 2019-01-18 | 2019-01-30 | Avelumab | 02 | null | VENETOCLAX | 100487879 |
| 10480051 | 10054607 | 1.55 | 79.5 | null | 2016-09-01 | 2016-09-08 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101520253 |
| 10480092 | 10054608 | 1.76 | 76 | null | 2014-11-29 | 2015-02-11 | RUXOLITINIB | 02 | null | CARBOPLATIN + GEMCITABINE | 101768505 |
| 10480208 | 10054609 | 1.72 | 91.7 | Palliative (P) | null | 2021-07-04 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100621620 |
| 10480215 | 10054610 | 1.68 | 69.1 | null | 2017-11-26 | 2017-12-01 | Avelumab | 02 | null | DARATUMUMAB | 100454175 |
| 10480231 | 10054611 | 1.77 | 0 | null | 2013-02-17 | 2015-12-24 | RUXOLITINIB | N | null | RUXOLITINIB | 100246615 |
| 10480246 | 10054612 | 1.75 | 114.8 | null | null | 2020-11-15 | Avelumab | 02 | null | TRASTUZUMAB | 101323307 |
| 10480270 | 10054613 | 1.7 | 80 | 03 | 2017-09-08 | 2017-09-17 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100580314 |
| 10480273 | 10054614 | 1.72 | 124.2 | null | 2017-06-10 | 2017-06-23 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100873356 |
| 10480357 | 10054615 | 1.7 | null | null | 2019-07-22 | 2019-08-04 | Avelumab | 02 | null | NIVOLUMAB | 101619979 |
| 10480360 | 10054616 | 1.75 | 105 | null | 2016-03-15 | 2016-03-28 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100916815 |